Photo by drew_hays from unsplash
A hybrid drug delivery platform involving the fusion of cell membranes from U937 monocytes and synthetic lipids to create nano-cell vesicle technology systems (nCVTs) is designed. nCVTs are engineered for… Click to show full abstract
A hybrid drug delivery platform involving the fusion of cell membranes from U937 monocytes and synthetic lipids to create nano-cell vesicle technology systems (nCVTs) is designed. nCVTs are engineered for a targeted approach towards tumour sites by preserving key surface proteins from U937 monocytes, while being amendable to functionalization and loading due to their liposomal components.
Keywords:
hybrid smart;
tumour;
platform;
ncvts hybrid;
tumour targeting;
smart tumour
Journal Title: Nanoscale
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nanoscale
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!